Table 4 Association of BA slope with cancer incidence after 8-year follow-up

From: Epigenetic aging and cancer incidence in a German cohort of older adults

Predictors

Cancer free (N = 625)

Incident cancer (N = 159)

Model 1

 

Model 2

 

Median (IQR)

Median (IQR)

HR per SD (95%CI)

p-value

HR per SD (95%CI)

p-value

PCHorvath slope

0.52 (0.38 - 0.68)

0.59 (0.45 - 0.74)

1.29 (1.11 - 1.49)

7.42E-4

1.37 (1.16 - 1.61)

1.86E-4

PCSkinBloodClock slope

0.46 (0.27 - 0.65)

0.53 (0.36 - 0.69)

1.26 (1.07 - 1.48)

0.005

1.33 (1.12 - 1.59)

0.001

PCHannum slope

0.58 (0.35 - 0.78)

0.65 (0.48 - 0.85)

1.25 (1.06 - 1.48)

0.008

1.34 (1.11 - 1.61)

0.002

PCPhenoAge slope

0.56 (0.13 - 0.91)

0.63 (0.30 - 0.95)

1.26 (1.06 - 1.51)

0.010

1.34 (1.11 - 1.62)

0.002

PCGrimAge slope

0.61 (0.42 - 0.78)

0.64 (0.48 - 0.78)

1.17 (0.99 - 1.38)

0.072

1.24 (1.04 - 1.48)

0.018

  1. Model 1: Cox proportional-hazard regression adjusted age, sex, blood cell composition and batch of measurements.
  2. Model 2: additionally adjusting for BMI, smoking, and alcohol consumption, physical activity and family history of cancer.
  3. The bold printed p-values passed Bonferroni-correction (0.05/5).